Jenkins Lab

Wonderful to see so many people attend the Annual @SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker @marazeissig. Thank you to everyone. youtube.com/watch?v=z2KcRI…

Very pleased to share our latest published work on the role of the innate immune inflammasome adaptor ASC in promoting pancreatic cancer. Thanks to all in our multinational team! @SAiGENCI @NatureComms pubmed.ncbi.nlm.nih.gov/41654528/

Great to see so many excellent presentations by national experts in inflammation, innate immunity and cell death at the 5th Annual Australian Inflammation Centres Symposium hosted by @SAiGENCI in Adelaide. Thanks to ASI Innate Immunity SIG, and @AusCellDeathSoc.

Very honoured to be the first Australian recipient of the prestigious Japanese Cancer Association (JCA) International Award, presented at the annual JCA2025 conference in Kanazawa. Special thanks to my JCA colleagues, especially JCA President, Prof Masanobu Oshima @SAiGENCI

We're hiring! Looking for highly talented Post-doctoral researchers to join our program at SAiGENCI (Adelaide University) to study the role of the immune system in cancer. See below for details..... careers.adelaide.edu.au/cw/en/job/5172… @SAiGENCI

Very grateful to the Ainsworth Foundation for their generous investment in our Tumour Inflammation and Immunotherapy Program. @SAiGENCI @UniofAdelaide #0" target="_blank" rel="nofollow noopener">adelaide.edu.au/newsroom/news/…

@SAiGENCI @Mohamed_I_Saad @CureCancerAu @UniofAdelaide Congratulations and very deserved!

👏Congratulations to @Mohamed_I_Saad on your @CureCancerAu Researcher of the Year 2025 award. Proud to have you continuing your important work @SAiGENCI! 🧪🔬👊 @UniofAdelaide

@CureCancerAu @Mohamed_I_Saad Congratulations Mohamed from everyone at SAiGENCI. @SAiGENCI

Congratulations to Dr Mohammed Saad! Dr Saad is a molecular biologist and lung cancer researcher based at the University of Adelaide. His work has led to collaborations with major pharmaceutical companies, and his research appears in top-tier journals.

Great to see a full-house for @SAiGENCI's third Annual Public Lecture on Tuesday night featuring @Lab_Jenkins and @marazeissig speaking on the topic of "Fighting cancer from within: your immune system may hold the key" youtube.com/watch?v=z2KcRI… @UniofAdelaide

Wonderful to see so many people attend the Annual @SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker @marazeissig. Thank you to everyone. youtube.com/watch?v=z2KcRI…

"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions." nature.com/articles/d4158…… please come join bsky.app/profile/cytoki… on Bluesky!!!

Hi all, we're now on Bluesky also. Make the move like others are and we'll see you there too...... @jenkins-lab.bsky.social

@marazeissig Well done Mara, look forward to seeing this project up and running in our program 👏👏👏 @SAiGENCI

Excited to have been awarded a Tour de Cure grant to work on KRAS inhibitors in pancreatic cancers. Marks the first grant (of hopefully many!) for my new lab at SAiGENCI 🎉

@Mohamed_I_Saad @SAiGENCI @UniofAdelaide Congratulations again Mohamed, fantastic achievement, can't wait to get this work started for our program....👏👏👏

I am very pleased and honoured to announce that our team has been awarded an NHMRC Ideas grant starting 2025 to study proteases as therapeutic targets in small cell lung cancer. Special thanks to my mentors, collaborators and consumers. @Lab_Jenkins @SAiGENCI @UniofAdelaide

Announcing further @SAiGENCI grant success with @LanKhuyenNguyen, @marazeissig and @drcilento awarded funding from @tourdecure_aus to further their work in prostate and pancreatic cancers. Read more at adelaide.edu.au/newsroom/news/… @UniofAdelaide 👏👊🎉